Sovaldi Among New HCV Drugs In Turkey Reimbursement Pact
This article was originally published in PharmAsia News
Executive Summary
Turkey’s public health payer has added three new hepatitis C drugs to the reimbursement list through a special deal with manufacturers, although the price the SGK will be paying to the companies is not being revealed.